{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-23-000015","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2023-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.617113+00:00","generated_at":"2026-06-15T18:57:07.712736+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"USPH Q1 net income $0.58/share, revenue up 12.8% to $148.5M, reaffirms FY guidance","bullets":["Q1 net income attributable to USPH $7.4M ($0.58 diluted EPS) vs $8.8M ($0.67) YoY; operating income up 13.1% to $17.0M.","Adjusted EBITDA $18.5M (record Q1) up from $17.5M; patient visits increased 15.4% to 1,227,490.","Average visits per clinic per day 29.8 (all-time Q1 high); physical therapy margin improved to 21.0% from 20.0%.","Quarterly dividend $0.43/share declared, payable June 9, 2023 to holders of record May 18, 2023.","Reaffirmed FY2023 Adjusted EBITDA guidance $75–80M; acquired 80% of a clinic ($3.2M annual revenue) and opened 7 clinics."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-23-000015","json":"https://secwatch.observer/filing/0000885978-23-000015.json","markdown":"https://secwatch.observer/filing/0000885978-23-000015.md","text":"https://secwatch.observer/filing/0000885978-23-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000015/0000885978-23-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000015/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T18:57:07.712736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da8bc03c82ae923c80d4467a11a6a295233a3c4f","claim":"U S PHYSICAL THERAPY INC /NV reported three months ended March 31, 2023 results: revenue $148.5 million, net income $7.4 million, EPS $0.58 per diluted share. Guidance reaffirmed.","evidence_excerpt":"Total net revenue for 2023 First Quarter was $148.5 million, an increase of 12.8%, compared to $131.7 million for the 2022 First Quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000015/0000885978-23-000015-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2023"},{"label":"Revenue","value":"$148.5 million"},{"label":"Net income","value":"$7.4 million"},{"label":"EPS","value":"$0.58 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}